Allen Moseley

Allen Moseley joined NMP in 1998 and leads the firm’s healthcare practice focused primarily on healthcare information technology and healthcare services. He currently also represents NMP on the boards of Hospicelink, Navitas Lease Finance, Novu, RemitDATA, Streamline Health Solutions (NASDAQ: STRM), and Wellcentive, and serves as a board observer for Advance Health. Allen was previously a director for several prior NMP investments including Apex Analytix (acquired by PNC Equity), Bloodhound Technologies (acquired by Verisk Analytics), Lanx (acquired by Biomet, Inc.), Renal CarePartners (acquired by Ambulatory Services of America), Senior Whole Health (acquired by TA Associates), U.S. Radiosurgery (acquired by Alliance Imaging), Valor Healthcare (acquired by Humana) and Witness Systems (board observer, IPO and acquired by Verint Systems).

Prior to joining NMP, Allen was in the corporate finance group at The Robinson-Humphrey Company, an investment banking firm previously owned by Citigroup and most recently acquired by SunTrust. Allen worked extensively in the healthcare and business services industries, advising on a number of initial public offerings, M&A transactions, and private placements. He was also involved in R-H Capital Partners, the private equity investment arm of the firm. Previously, Allen held investment banking positions with Bowles Hollowell Conner & Company and Merrill Lynch & Co.